Gelderblom, H. et al. (2003) Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors. Clinical Cancer Research, 9, pp. 4101-4107.
Full text not currently available from Enlighten.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Devlin, Mr Mark |
Authors: | Gelderblom, H., Salazar, R., Verweij, J., Pentheroudakis, G., de Jonge, M.J.A., Devlin, M., van Hooije, C., Seguy, F., Obach, R., Prunonosa, J., Principe, P., and Twelves, C. |
College/School: | College of Medical Veterinary and Life Sciences |
Journal Name: | Clinical Cancer Research |
University Staff: Request a correction | Enlighten Editors: Update this record